Auto-retractable Safety Syringe Market By Type (0.5ml capacity, 1 ml Capacity, 3 ml capacity, Others) , By Application (Intramuscular, Subcutaneous, Intravenous) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Auto-retractable Safety Syringe Market
The auto-retractable safety syringe market was valued at $3.2 billion in 2023 and is projected t%li%reach $4.8 billion by 2033, growing at a CAGR of 4% from 2024 t%li%2033.
An auto-retractable safety syringe is a form of syringe integrated with the safety feature of one-click coaxial needle retraction. Once the plunger handle of the syringe depresses completely, the needle automatically withdraws itself from the patient’s body t%li%the syringe barrel. The key benefit of a safety syringe includes reduced needlestick injury risk and decreased exposure t%li%contaminated needles.
Increase in healthcare expenditure and advancements in the tools & equipment used in healthcare settings are the primary drivers of the auto-retractable safety syringe market. In addition, rise in the prevalence of transmissible diseases is boosting the adoption of auto-retractable safety syringes in different types of healthcare facilities and clinics. Furthermore, the implementation of stringent regulations by governments, such as the Needlestick Safety and Prevention Act in the U.S., is promoting the use of safety syringes and augmenting the market development. In recent times, the trend of prefilled auto-retractable safety syringes is acquiring traction in the market. These syringes enhance the safety of patients through accurate dosage delivery and easy self-administration attributes. This form of safety syringes is projected t%li%dominate the market in the future as remote treatments and self-medication are poised t%li%be the future of the healthcare industry.
However, the cost of retractable syringes is higher than the conventional syringes, deterring their adoption in small-scale healthcare settings & remote locations and hampering the growth of the market. In addition, the World Health Organization has implemented some mandatory guidelines regarding the use of safety syringes, compliance with which restrains the market growth. Contrarily, rapid surge in the prevalence of needlestick injuries is expected t%li%present new avenues for the auto-retractable safety syringe market. As per a report published on the National Library of Medicine, around four percent of the total hepatitis C cases arise due t%li%needlestick injuries. This is projected t%li%boost the use of auto-retractable safety syringes in the coming future.
Segment Review
The auto-retractable safety syringe market is segmented int%li%type, application, and region. On the basis of type, the market is divided int%li%0.5ml capacity, 1 ml capacity, 3 ml capacity, and others. Depending on application, it is classified int%li%intramuscular, subcutaneous, and intravenous. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the 0.5ml capacity segment witnesses a high demand in the market.
Depending on application, the intravenous segment dominates the auto-retractable safety syringe market.
Region wise, North America is projected t%li%be the highest revenue generator by 2033.
Competition Analysis
The key players operating in the global auto-retractable safety syringe market include BD (Becton, Dickinson and Company), Smiths Medical, Terum%li%Corporation, Retractable Technologies, Inc., Medtronic plc, Nipr%li%Corporation, Globe Medical Tech, Inc, Revolutions Medical Corporation, Sol-Millennium, and DMC Medical Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Type
The auto-retractable safety syringe market was valued at $3.2 billion in 2023 and is projected t%li%reach $4.8 billion by 2033, growing at a CAGR of 4% from 2024 t%li%2033.
An auto-retractable safety syringe is a form of syringe integrated with the safety feature of one-click coaxial needle retraction. Once the plunger handle of the syringe depresses completely, the needle automatically withdraws itself from the patient’s body t%li%the syringe barrel. The key benefit of a safety syringe includes reduced needlestick injury risk and decreased exposure t%li%contaminated needles.
Increase in healthcare expenditure and advancements in the tools & equipment used in healthcare settings are the primary drivers of the auto-retractable safety syringe market. In addition, rise in the prevalence of transmissible diseases is boosting the adoption of auto-retractable safety syringes in different types of healthcare facilities and clinics. Furthermore, the implementation of stringent regulations by governments, such as the Needlestick Safety and Prevention Act in the U.S., is promoting the use of safety syringes and augmenting the market development. In recent times, the trend of prefilled auto-retractable safety syringes is acquiring traction in the market. These syringes enhance the safety of patients through accurate dosage delivery and easy self-administration attributes. This form of safety syringes is projected t%li%dominate the market in the future as remote treatments and self-medication are poised t%li%be the future of the healthcare industry.
However, the cost of retractable syringes is higher than the conventional syringes, deterring their adoption in small-scale healthcare settings & remote locations and hampering the growth of the market. In addition, the World Health Organization has implemented some mandatory guidelines regarding the use of safety syringes, compliance with which restrains the market growth. Contrarily, rapid surge in the prevalence of needlestick injuries is expected t%li%present new avenues for the auto-retractable safety syringe market. As per a report published on the National Library of Medicine, around four percent of the total hepatitis C cases arise due t%li%needlestick injuries. This is projected t%li%boost the use of auto-retractable safety syringes in the coming future.
Segment Review
The auto-retractable safety syringe market is segmented int%li%type, application, and region. On the basis of type, the market is divided int%li%0.5ml capacity, 1 ml capacity, 3 ml capacity, and others. Depending on application, it is classified int%li%intramuscular, subcutaneous, and intravenous. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the 0.5ml capacity segment witnesses a high demand in the market.
Depending on application, the intravenous segment dominates the auto-retractable safety syringe market.
Region wise, North America is projected t%li%be the highest revenue generator by 2033.
Competition Analysis
The key players operating in the global auto-retractable safety syringe market include BD (Becton, Dickinson and Company), Smiths Medical, Terum%li%Corporation, Retractable Technologies, Inc., Medtronic plc, Nipr%li%Corporation, Globe Medical Tech, Inc, Revolutions Medical Corporation, Sol-Millennium, and DMC Medical Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Average Selling Price Analysis / Price Point Analysis
- Historic market data
- Reimbursement Scenario
By Type
- 0.5ml capacity
- 1 ml Capacity
- 3 ml capacity
- Others
- Intramuscular
- Subcutaneous
- Intravenous
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- BD (Becton, Dickinson and Company)
- Smiths Medical
- Terum%li%Corporation
- Retractable Technologies, Inc.
- Medtronic plc
- Nipr%li%Corporation
- Globe Medical Tech, Inc
- Revolutions Medical Corporation
- sol-millennium
- DMC Medical Limited
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: BIOPROCESS BAGS MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. 2D Bioprocess Bags
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. 3D Bioprocess Bags
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: BIOPROCESS BAGS MARKET, BY WORKFLOW
5.1. Market Overview
5.1.1 Market Size and Forecast, By Workflow
5.2. Upstream Process
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Downstream Process
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Process Development
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: BIOPROCESS BAGS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Pharmaceutical And Biopharmaceutical Companies
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. CMOs And CROs
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Academic And Research Institute
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: BIOPROCESS BAGS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Workflow
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Bioprocess Bags Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Workflow
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Bioprocess Bags Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Workflow
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Bioprocess Bags Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Workflow
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Workflow
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Bioprocess Bags Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Workflow
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Bioprocess Bags Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Workflow
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Bioprocess Bags Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Workflow
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Bioprocess Bags Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Workflow
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Bioprocess Bags Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Workflow
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Bioprocess Bags Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Workflow
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Workflow
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Bioprocess Bags Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Workflow
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Bioprocess Bags Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Workflow
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Bioprocess Bags Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Workflow
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Bioprocess Bags Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Workflow
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Bioprocess Bags Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Workflow
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Bioprocess Bags Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Workflow
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Workflow
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Bioprocess Bags Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Workflow
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Bioprocess Bags Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Workflow
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Bioprocess Bags Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Workflow
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Bioprocess Bags Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Workflow
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Thermo Fisher Scientific Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Sartorius AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Merck KGaA
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Danaher Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Saint-Gobain Performance Plastics.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Lonza Group AG
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Eppendorf AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Meissner Filtration Products, Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. PBS Biotech, Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. GE Healthcare
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: BIOPROCESS BAGS MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. 2D Bioprocess Bags
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. 3D Bioprocess Bags
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: BIOPROCESS BAGS MARKET, BY WORKFLOW
5.1. Market Overview
5.1.1 Market Size and Forecast, By Workflow
5.2. Upstream Process
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Downstream Process
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Process Development
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: BIOPROCESS BAGS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Pharmaceutical And Biopharmaceutical Companies
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. CMOs And CROs
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Academic And Research Institute
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: BIOPROCESS BAGS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Workflow
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Bioprocess Bags Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Workflow
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Bioprocess Bags Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Workflow
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Bioprocess Bags Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Workflow
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Workflow
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Bioprocess Bags Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Workflow
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Bioprocess Bags Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Workflow
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Bioprocess Bags Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Workflow
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Bioprocess Bags Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Workflow
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Bioprocess Bags Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Workflow
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Bioprocess Bags Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Workflow
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Workflow
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Bioprocess Bags Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Workflow
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Bioprocess Bags Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Workflow
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Bioprocess Bags Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Workflow
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Bioprocess Bags Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Workflow
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Bioprocess Bags Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Workflow
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Bioprocess Bags Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Workflow
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Workflow
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Bioprocess Bags Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Workflow
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Bioprocess Bags Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Workflow
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Bioprocess Bags Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Workflow
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Bioprocess Bags Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Workflow
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Thermo Fisher Scientific Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Sartorius AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Merck KGaA
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Danaher Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Saint-Gobain Performance Plastics.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Lonza Group AG
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Eppendorf AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Meissner Filtration Products, Inc.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. PBS Biotech, Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. GE Healthcare
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
